Ron Hunt is a Co-Founder and Managing Director at New Leaf Venture Partners. See sector focus and contact routes.
Ron Hunt is a Co-Founder and Managing Director at New Leaf Venture Partners, a New York-based venture capital firm he established in 2005 after the spin-out from the Sprout Group. He focuses on early to late-stage investments exclusively in biopharmaceuticals and healthcare technology, targeting clinical-stage companies and life science tools that address unmet medical needs. While specific check sizes and lead/follow behavior for Hunt individually are not publicly detailed, New Leaf has executed deals ranging up to $24 million in Series B rounds, such as its April 2024 investment in Qlaris Bio. Notable portfolio companies include Qlaris Bio, a clinical-stage biopharmaceutical firm, and other healthcare technology ventures within New Leaf’s 22 tracked company portfolio. Hunt brings over 25 years of experience in venture capital and previously worked as a strategy consultant and in sales roles at Johnson & Johnson and SmithKline Beecham Pharmaceuticals. There is no publicly available distinctive point of view or published writing by Hunt beyond his firm’s mission to revolutionize healthcare through innovative technologies.
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in New York when building a target list.
Investors like Ron Hunt · Full investor directory · Investor access · Company funding database